Table 3

A summary of the results from the validation of Idylla against Ion Torrent (Ion) NGS and IHC for BRAF, KRAS and NRAS

BRAF
Ion NGS BRAF mutantIon NGS BRAF wild typeTotal
Idylla BRAF+808
Idylla BRAF099
Total8917
VE1 IHC BRAF mutantVE1 IHC BRAF wild typeTotal
Idylla BRAF+10010
Idylla BRAF2*810
Total12820
Idylla concordance with IHC: 90% (95% CI 70% to 97%)
Idylla concordance with Ion NGS: 100% (95% CI 82% to 100%)
Idylla sensitivity (vs Ion NGS): 100% (95% CI 68% to 100%)
Idylla specificity (vs Ion NGS): 100% (95% CI 70% to 100%)
KRAS
Ion NGS KRAS mutantIon NGS KRAS wild typeTotal
Idylla KRAS+909
Idylla KRAS099
Total9918
Idylla concordance: 100% (95% CI 82% to 100%)
Idylla sensitivity: 100% (95% CI 70% to 100%)
Idylla specificity: 100% (95% CI 70% to 100%)
NRAS
Ion NGS NRAS mutantIon NGS NRAS wild typeTotal
Idylla NRAS+51†6
Idylla NRAS01111
Total51217
Idylla concordance with Ion NGS: 94% (95% CI 73% to 99%)
Idylla sensitivity: 100% (95% CI 57% to 100%)
Idylla specificity: 92% (95% CI 65% to 99%)
All targets
Ion NGS/ddPCR mutantIon NGS wild typeTotal
Idylla+24024
Idylla−02828
Total242852
Idylla concordance with Ion NGS/ddPCR: 100% (95% CI 93% to 99%)
Idylla sensitivity: 100% (95% CI 86% to 100%)
Idylla specificity: 100% (95% CI 88% to 99%)
  • *Found to be wild type by Cobas PCR.

  • †Found to be positive for a mutation by ddPCR.

  • ddPCR, droplet digital polymerase chain reaction; IHC, immunohistochemistry; NGS, next-generation sequencing.